SG18688G - Use of 3-beta-methoxy-ethyl 5-isopropy 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine(sic)for the preparation of medicaments having cerebral activity - Google Patents

Use of 3-beta-methoxy-ethyl 5-isopropy 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine(sic)for the preparation of medicaments having cerebral activity

Info

Publication number
SG18688G
SG18688G SG186/88A SG18688A SG18688G SG 18688 G SG18688 G SG 18688G SG 186/88 A SG186/88 A SG 186/88A SG 18688 A SG18688 A SG 18688A SG 18688 G SG18688 G SG 18688G
Authority
SG
Singapore
Prior art keywords
isopropy
nitrophenyl
medicaments
sic
dihydro
Prior art date
Application number
SG186/88A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6036687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG18688(G) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SG18688G publication Critical patent/SG18688G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
SG186/88A 1978-04-11 1988-03-23 Use of 3-beta-methoxy-ethyl 5-isopropy 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine(sic)for the preparation of medicaments having cerebral activity SG18688G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2815578A DE2815578C2 (de) 1978-04-11 1978-04-11 Neue pharmazeutische Verwendung von Nimodipin

Publications (1)

Publication Number Publication Date
SG18688G true SG18688G (en) 1989-07-07

Family

ID=6036687

Family Applications (1)

Application Number Title Priority Date Filing Date
SG186/88A SG18688G (en) 1978-04-11 1988-03-23 Use of 3-beta-methoxy-ethyl 5-isopropy 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine(sic)for the preparation of medicaments having cerebral activity

Country Status (27)

Country Link
US (1) US4406906A (it)
EP (1) EP0004650B1 (it)
JP (3) JPS54135776A (it)
AT (1) AT383271B (it)
AU (1) AU532623B2 (it)
BE (1) BE875457A (it)
CA (1) CA1140853A (it)
CH (3) CH649921A5 (it)
DE (2) DE2815578C2 (it)
DK (1) DK150479A (it)
ES (1) ES479474A1 (it)
FI (1) FI791162A7 (it)
FR (1) FR2422402A1 (it)
GB (1) GB2018134A (it)
GR (1) GR71463B (it)
HK (1) HK59188A (it)
IE (1) IE51651B1 (it)
IL (1) IL57030A (it)
IT (1) IT1062201B (it)
LU (2) LU88273I2 (it)
NL (2) NL7902778A (it)
NO (1) NO791009L (it)
NZ (1) NZ190133A (it)
PH (1) PH15574A (it)
SE (1) SE447248B (it)
SG (1) SG18688G (it)
ZA (1) ZA791728B (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
JPS58172312A (ja) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk ニフエジピン外用剤
JPS58177916A (ja) * 1982-04-13 1983-10-18 Kowa Co 外用剤
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4758669A (en) * 1986-05-05 1988-07-19 Radiation Oncology Center Research And Development Corporation 4-(nitrone aryl) dihydropyridines
US5401759A (en) * 1989-11-16 1995-03-28 Miles Inc. Nimodipine enhanced growth and vascularization of neural grafts
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
JP2793410B2 (ja) * 1991-04-22 1998-09-03 インターナショナル・ビジネス・マシーンズ・コーポレイション ウェブ駆動装置及びテープ駆動装置
US5438144A (en) * 1991-07-30 1995-08-01 Troponwerke Gmbh & Co. Kg Use of 1,4-dihydropyridines in diabetes
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
IT1255792B (it) * 1992-08-05 1995-11-16 Bayer Italia Spa Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
DE59304885D1 (de) * 1992-10-30 1997-02-06 Bayer Ag 4-Heterocyclophenyl substituierte Dihydropyridine
SE9203857D0 (sv) * 1992-12-22 1992-12-22 Astra Ab Use of an enantiomeric dihydropyridine
EP0657432B1 (de) 1993-12-10 2003-03-12 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4430094A1 (de) * 1994-08-25 1996-02-29 Bayer Ag Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel
DE4443168A1 (de) * 1994-12-05 1996-06-13 Bayer Ag Neues hochselektives Verfahren zur Herstellung von enantiomerenreinen phenylsubstituierten 1,4-Dihydropyridin-3,5-dicarbonsäurederivaten
US6078481A (en) * 1998-06-08 2000-06-20 Imation Corp. Tape storage cartridge having two-level tape path
AR027152A1 (es) * 2000-12-29 2003-03-12 Osmotica Argentina S A Composicion farmaceutica para el tratamiento de la enfermedad cerebrovascular cognitiva.
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2007047406A2 (en) * 2005-10-14 2007-04-26 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
WO2009032286A2 (en) 2007-09-06 2009-03-12 Nektar Therapeutics Al, Corporation Oligomer-calcium channel blocker conjugates
US9737478B2 (en) * 2009-09-28 2017-08-22 National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) Treatment of malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives

Also Published As

Publication number Publication date
CH649921A5 (de) 1985-06-28
CH640734A5 (de) 1984-01-31
AU532623B2 (en) 1983-10-06
EP0004650B1 (de) 1986-01-29
LU88273I2 (it) 1994-02-03
IT1062201B (it) 1983-07-29
FI791162A7 (fi) 1981-01-01
ES479474A1 (es) 1979-12-16
NL930034I2 (nl) 1993-10-01
IL57030A (en) 1982-09-30
BE875457A (fr) 1979-10-10
ATA262179A (de) 1986-11-15
JPS591412A (ja) 1984-01-06
US4406906A (en) 1983-09-27
FR2422402A1 (fr) 1979-11-09
AU4583579A (en) 1979-10-18
GR71463B (it) 1983-05-30
LU81133A1 (de) 1979-11-07
IL57030A0 (en) 1979-07-25
IE790756L (en) 1979-10-11
JPS58219117A (ja) 1983-12-20
AT383271B (de) 1987-06-10
NZ190133A (en) 1985-02-28
IT7921692A0 (it) 1979-04-09
DK150479A (da) 1979-10-12
HK59188A (en) 1988-08-12
GB2018134A (en) 1979-10-17
NL930034I1 (nl) 1993-08-02
NO791009L (no) 1979-10-12
JPS54135776A (en) 1979-10-22
CH649468A5 (de) 1985-05-31
CA1140853A (en) 1983-02-08
PH15574A (en) 1983-02-17
FR2422402B1 (it) 1982-07-02
NL7902778A (nl) 1979-10-15
DE2815578A1 (de) 1979-10-18
DE2815578C2 (de) 1986-01-16
EP0004650A1 (de) 1979-10-17
SE7903186L (sv) 1979-10-12
IE51651B1 (en) 1987-02-04
ZA791728B (en) 1980-05-28
JPS5730089B2 (it) 1982-06-26
SE447248B (sv) 1986-11-03
DE2967573D1 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
DE2967573D1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs
DE2962241D1 (en) Process for the preparation of derivatives of 1,4-dihydropyridine-3-carboxylic acid, derivatives of 1,4-dihydropyridine-3-carboxylic acid and the use of these derivatives for the preparation of 1,4-dihydropyridine-3,5-dicarboxylates
AR243878A1 (es) Procedimiento para la preparacion de 2-oxo-1,3-dioxolanos.
PH19006A (en) Process for the preparation of new optically active 1,4-dihydropyridine
NO169121C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 9-amino-1,2,3,4-tetrahydroakridin-1-oler
NO873205L (no) Fremgangsmaate for fremstilling av carbapenemforbindelser i krystallinsk form.
IL81950A (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them
IL54429A (en) 2-aminoalkylene dihydropyridine compounds,their production and pharmaceutical compositions containing them
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
ZA777532B (en) 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same
EP0210647A3 (en) Pyridazinone derivatives, process for preparation thereof and insecticidal compositions
NZ187617A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
PL268618A1 (en) The method of manufacture of 1,4-dihydropyridine derivatives
FI873144A7 (fi) Menetelmä sykloalkyyli-substituoitujen 4-pyridyylijohdannaisten valmistamiseksi.
GR870824B (en) Process for the preparation of new 1,4 - dihydropyridines useful as antithrombotic drugs
GB2013186B (en) Derivative of 1,4 dihydropyridine
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
GR82568B (en) Process for the preparation of 1,3-dioxolanyl derivatives, use thereof, medicaments containing said compounds
GB2190678B (en) 3-(hydroxymethyl)-isoquinoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
EP0042093A3 (en) 4-aralkyl-1,4-dihydropyridines, processes for praparing them, their use as medicines and preparation thereof
EP0371492A3 (en) Process for the preparation of 1,4-dihydropyridine derivatives
GB2216521B (en) Process for the preparation of 1,4-dihydro-pyridine derivatives
GB2196631B (en) 2-substituted 1,4-dihydropyridine derivatives
PT79630A (en) Process for the preparation of 1,2,4-oxo(tio)diazoline-3-one derivatives